| Product Name | : | Olaparix |
| Generic Name | : | Olaparib |
| Formulation | : | Tablet |
| Available Pack Size | : | 120s pot |
| Available Strength | : | 150 mg |
| Registrations | : | Export Only |
| Website | : | Olaparix.com |
-
Product Description: Olaparix, is tablet and capsule forms, in treating the people suffering from ovarian and breast cancer. Olaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor that is primarily indicated in treating ovarian and breast cancer. Product Features: -
Product Description: Beacon Medicare Limited (BML) has launched new anti-cancer drugs in injection form under the brand name “Nivolunix,”.The medicine under the generic of Nivolumab INN is expected to accelerate cancer immunotherapy and will also be used in treating melanoma, lung, head and neck cancer, Hodgkin lymphoma and Hepatocellular carcinoma (HCC). It is suggested for slow injection into vein of the patients suffering from such type of cancer only for export purpose. Product Features:Product Name : Nivolunix Generic Name : Nivolumab Formulation : Injection Available Pack Size : 1’s Vial Available Strength : 100mg/10ml Registrations Available -
Product Description: First new frontline treatment option for HCC approved in Japan Lenvatinib is amultikinase inhibitor that interrupts the pathways of VEGFR1,VEGFR2 and VEGFR3.It is used in the treatment of differentiated thyroid cancer (DTC),renal Cell Carcinoma and Hepatocellular Carcinoma (HCC) Product Features:Product Name : Lenvanix Generic Name : Lenvatinib Formulation : Capsule Available Pack Size : 30's Pot Available Strength : 4 mg and 10 mg Registrations Available Website : Lenvanix.com -
Product Description: Ibrutix (Ibrutinib) is a kinase inhibitor indicated for the treatment of patients with: Mantle Cell Lymphoma (MCL) who have received at least one prior therapy, Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) with 17p deletion, Waldenström’s Macroglobulinemia (WM), Marginal Zone Lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy. Ibrutix is available in capsule form for oral administration. Capsules should be taken orally with a glass of water. Do not open, break, or chew the capsules.
Product Features:
Product Name : Ibrutix Generic Name : Ibrutinib INN Formulation : Capsule Available Pack Size : 120’s in a bottle Available Strength : 140 mg Registrations : Avaiable Website : www.ibrutix.com -
Product Description: Afatinib is a kinase inhibitor indicated for the First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test & treatment of patients with metastatic, squamous NSCLC progressing after platinum-based chemotherapy. Afanix is available in tablet form for oral administration. The recommended dose of Afatinib is 40 mg orally, once daily until disease progression or no longer tolerated by the patient.
Product Features:
Product Name : Afanix Generic Name : Afatinib Dimaleate INN Formulation : Tablet Available Pack Size : 30's (3x10’s) Available Strengths : 40 mg Registrations : Available Website : www.afanix.com -
Product Description: DASANIX (Dasatinib) is a kinase inhibitor. Dasatinib is a white to off-white powder.
Product Features:
Product Name : Dasanix Generic Name : Dasatinib Formulation : Tablet Available Pack Size : 3x10’s Available Strengths : 20 mg Registrations : Available Website : www.dasanix.com -
Product Description: DASANIX (Dasatinib) is a kinase inhibitor. Dasatinib is a white to off-white powder.
Product Features:
Product Name : Dasanix Generic Name : Dasatinib Formulation : Tablet Available Pack Size : 6x10’s Available Strengths : 50 mg Registrations : Available Website : www.dasanix.com -
Product Description:
Regorafenib is an oral multi-kinase inhibitor involved in normal cellular functioning and in pathological processes such as oncogenesis, tumor angiogenesis, metastasis, and tumor immunity.It is used in the therapy of metastatic colorectal cancer , gastrointestinal stromal tumor and hepatocellular carcinoma (HCC) who have been previously treated with Sorafenib. Product Features:
Categories: Anti-CancerProduct Name : Regonix Generic Name :Regorafenib Formulation : Tablet Available size : 28’s Strengths : 40mg Registrations : Available Website : www.regonix.com -
Product Description: Crizotinib is a kinase inhibitor indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive or ROS 1 positive. Crizotinib is the first FDA-approved biomarker-driven therapy for both ALK positive and ROS1-positive metastatic NSCLC. It is the only FDA approved drug for ROS 1 positive NSCLC.
Indication: CRIZONIX i is indicated for the first-line treatment of adults with ALK-positive advanced NSCLC and for the treatment of adults with previously treated ALK-positive advanced NSCLC & ROS1 (+) NSCLC. Crizotinib is an ALK and ROS1 (c-ros oncogene 1, receptor tyrosine kinase) inhibitor.
Categories: OncologyProduct Name : Crizonix Generic Name : Crizotinib Formulation : Capsule Available size : 28’s Strengths : 250mg -
(Osimertinib)Tagrix Osimertinib (Tagrix) is the 1st and only drug of its kind approved by USFDA for the treatment of epidermal growth factor receptor (EGFR) positive Non- Small Cell Lung Cancer (NSCLC) patient with T790M mutation. Therapeutic indications TAGRIX is indicated for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC). Product Name : Tagrix Generic Name : Osimertinib Formulation : Tablet Available Pack size : 30’s Strengths : 40mg & 80mg Website : www.tagrix.net -
Product Description: TEMONIX contains temozolomide, an imidazotetrazine derivative. The chemical name of temozolomide is 3,4-dihydro-3methyl-4-oxoimidazo[5,1-d]-as-tetrazine-8-carboxamide.
Product Features:
Product Name : Temonix Generic Name : Temozolomide Formulation : Capsule Available Pack Size : 1x6’s(100 mg), 1x4’s (250 mg) Available Strengths : 100 mg & 250 mg Registrations : Bangladesh -
Product Description: SORANIX, a kinase inhibitor, is the tosylate salt of sorafenib. Sorafenib tosylate has the chemical name 4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)N2methylpyridine-2-carboxamide 4-methylbenzenesulfonate.
Products Features:Product Name : Soranix Generic Name : Sorafenib Formulation : Tablet Available Pack Size : 5x6’s Available Strengths : 200 mg Registrations : Bangladesh